Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases. - Wikidata - awgldk - TriplyDB

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

http://www.wikidata.org/entity/Q37135023

about

The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors Moving forward with human papillomavirus immunotherapies.Head and Neck Carcinoma Immunotherapy: Facts and Hopes.Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells.Current status and future prospects for human papillomavirus vaccines.ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism.Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.Why Human Papillomavirus Acute Infections Matter.Therapeutic vaccines for high-risk HPV-associated diseases.Discrepancies in the evaluation of the safety of the human papillomavirus vaccine.The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications

P2860

Q26747516-626BFF03-B2C7-44F9-961B-89B81ADF21D1 Q28072532-C6D42540-8F97-47AA-A91D-7A8D0C8CC2E3 Q37473299-72A533A9-3D7E-46AD-B2EF-7C8765DC76F8 Q38650710-D18B9AF3-EC5A-4CFA-BD93-AD12E43C8C5B Q39415253-3EC09401-9D1C-4BE0-A950-95578D754BC1 Q40056541-A3D12A8B-22FC-49E0-B0B9-E6166C6A916F Q40091834-3A0A32DF-E110-4548-8D0A-914B3160E7D3 Q40367504-621C0404-31F8-47DD-A178-1CEC814BA78F Q41921051-17F8531C-D284-46C6-BE6A-3C3A252BD9E6 Q47255618-5AEBE9C0-D28F-46C8-9F7E-86FC357822AA Q55314094-C9AE4DA2-680C-473C-97F2-515FE8971B9A Q58738110-2262C54A-C66F-4104-B41F-55F28B615B58

P2860

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

http://www.wikidata.org/entity/Q37135023

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

@en

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

@nl

type

label

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

@en

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

@nl

prefLabel

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

@en

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

@nl

P1433

Q37135023-6F424C2C-B899-41B5-8432-801F0C46F9A4

P1476

Q37135023-22317548-26CF-441E-B2D3-F0B94F07E224

P2093

Q37135023-446F90B6-05FA-47ED-93C8-6F7598192321

Q37135023-A9BA4C56-5587-4E53-BFBB-F28F97A6DC13

Q37135023-BD6326D8-6765-44B2-896F-1E0835DF92A4

P2860

Q37135023-01251FB8-C6BF-4E32-A94B-1980A675DA47

Q37135023-03D2F10C-2ABE-4EFB-89C3-DA0BB0F18445

Q37135023-04190BF7-391A-4A45-ACCE-E66D92A93B5F

Q37135023-04FCF955-3547-4B2D-A4C2-2776FF9B8C63

Q37135023-057F9DA1-E8F7-4FCE-9564-061F9D4CEC27

Q37135023-07D939D5-26C4-496C-A19F-8BA26F3DF4DF

Q37135023-0811F447-66A3-4A9F-A53B-C93238B7F33E

Q37135023-0CC7EB72-AE4D-4B9B-B4F7-32AF36D7694F

Q37135023-0E2549C2-158D-42CE-BA04-59AB9633FB1B

Q37135023-0FC98F9C-18BE-4ECA-B795-0447D2864A6F

P304

Q37135023-D8589548-C9D0-4669-A960-4DD904C7553C

P31

Q37135023-6E227276-2D87-45F8-9467-0584D1208D98

P356

Q37135023-76CC89EE-9210-4E54-9DCA-DCA5D720E58E

P433

Q37135023-8917B064-D0BD-4A02-99DF-106903099819

P478

Q37135023-67602FCC-D1A4-4B11-AA1E-CE06E75C83DD

P50

Q37135023-196D0B3F-34C8-4859-8538-39E62FBE8731

Q37135023-FC4E9246-94B5-46AC-AE7A-0FD6275A1CD6

P577

Q37135023-0E31AC04-6DBC-4B6C-9288-C3421C8AAC05

P698

Q37135023-E5F57D13-3E56-4330-9014-C2E95EA2D464

P921

Q37135023-C79BC77D-75AE-4538-8436-0186CDB0BAB1

P932

Q37135023-E1DE95B6-9127-4273-B4B2-C59C541204C7

P356

21645515.2015.1136039

P1433

Human Vaccines & Immunotherapeutics

P1476

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases

@en

P2093

Andrew W Woodham

http://www.w3.org/2001/XMLSchema#string

Diane M Da Silva

http://www.w3.org/2001/XMLSchema#string

Mark H Einstein

http://www.w3.org/2001/XMLSchema#string

P2860

Role of human papillomaviruses in carcinogenesis

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function

BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus

P304

1418-1429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2015.1136039

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Joseph G Skeate

P577

2016-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26835746

http://www.w3.org/2001/XMLSchema#string

P921

P932

4964648

http://www.w3.org/2001/XMLSchema#string